ACLARION, INC. Interest Expense, Other
ACLARION, INC. (ACON) reported Interest Expense, Other of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2026-03-18
- ACLARION, INC. interest expense, other for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ACLARION, INC. interest expense, other for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ACLARION, INC. interest expense, other for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- ACLARION, INC. interest expense, other for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- ACLARION, INC. interest expense, other for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- ACLARION, INC. interest expense, other for fiscal 2024 was $535.47K, a 11.97% decline from fiscal 2023.
- ACLARION, INC. interest expense, other for fiscal 2023 was $608.29K.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month | Interest Expense, Other 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $0.00 derived: sum of 3 quarters · filed 2026-03-18 | $0.00 10-K · filed 2026-03-18 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $271.00 derived: sum of 4 quarters · filed 2026-03-18 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $271.00 derived: sum of 3 quarters · filed 2026-03-18 | $71.80K derived: sum of 4 quarters · filed 2026-03-18 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | $271.00 derived: sum of 2 quarters · filed 2026-03-18 | $71.80K derived: sum of 3 quarters · filed 2026-03-18 | $199.65K derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-12-31 | $271.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $71.80K derived: sum of 2 quarters · filed 2026-03-18 | $199.65K derived: sum of 3 quarters · filed 2026-03-18 | $535.47K 10-K · filed 2026-03-18 |
| 2024-09-30 | $71.53K 10-Q · filed 2025-11-12 | $199.38K derived: sum of 2 quarters · filed 2025-11-12 | $535.20K 10-Q · filed 2025-11-12 | $928.64K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $127.85K 10-Q · filed 2025-08-14 | $463.67K 10-Q · filed 2025-08-14 | $857.11K derived: sum of 3 quarters · filed 2025-08-14 | $1.02M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $335.82K 10-Q · filed 2025-05-15 | $729.26K derived: sum of 2 quarters · filed 2025-05-15 | $895.59K derived: sum of 3 quarters · filed 2025-05-15 | $942.73K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $393.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | $559.77K derived: sum of 2 quarters · filed 2025-04-09 | $606.91K derived: sum of 3 quarters · filed 2025-04-09 | $608.29K 10-K · filed 2025-04-09 |
| 2023-09-30 | $166.33K 10-Q · filed 2024-11-14 | $213.47K derived: sum of 2 quarters · filed 2024-11-14 | $214.85K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $47.14K 10-Q · filed 2024-08-14 | $48.52K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |